Hearing Screening and Diagnostic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Hearing Screening And Diagnostic Devices Market By Product (OAE/ABR Testing Devices, Audiometers, Otoscopes, And Tympanometers), Indication Type (Conductive Hearing Loss, Sensorineural Hearing Loss, And Combination Hearing Loss), End-User (Hospitals & Clinics, And Diagnostic Centers), and geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of hearing loss and surge in government and non-government programs for hearing loss
The hearing screening and diagnostic devices market was valued at USD 549.75 million in 2023 and is likely to register a CAGR of 3.96% during the forecast period from 2024 to 2030 to reach USD 692.37 million by 2030. The hearing screening and diagnostic devices market is primarily being boosted by the increasing prevalence of hearing loss due to hearing disorders, hereditary disorders, and birth complications, the rising geriatric population, surge in government and non-government programs for hearing loss, among others during the forecast period. Furthermore, the hearing screening and diagnostic devices market is anticipated to grow on account of a large number of ongoing research activities in this field, improvements in product development, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute to the overall growth of the hearing screening and diagnostic devices market during the forecast period from 2024-2030.

Hearing Screening And Diagnostic Devices Market Dynamics:

According to data published by the World Health Organization (WHO) 2021, in 2019, it was estimated that around 430 million people suffered from disabling hearing loss.

As per the above-mentioned source, globally over 509 million people in 2030 and 612 million in 2040 will be suffering from hearing loss. This number is projected to increase to around 711 million by the year 2050.

The WHO 2019 data stated that in East Asia the number of people with disabling hearing loss is projected to increase to around 189 million by the year 2050. Also, there will be around 72 million cases of hearing loss in high-income countries, 44 million in the Middle East and North Africa, and 46 million in Central/East Europe and Central Asia by 2050.

The increase in bacterial and viral infections worldwide affecting ear, nose, and throat health is also causing a rise in the demand for hearing screening and diagnostic devices. For instance, according to WHO data published in 2021, the probability of an individual facing long-term effects such as loss of hearing, speech, and communication after recovering from bacterial meningitis is 1 out of 5.

As per the statistics provided by the World Health Organization 2021, it was estimated that approximately 16% of hearing loss in adults results from exposure to excessive noise in the workplace, globally. Thus, increasing noise pollution is also one of the factors contributing to the increasing prevalence of hearing loss, which in turn will contribute to the growth of the hearing screening and diagnostic devices market.

Thus, as per the factors mentioned above, there will be an increased demand for hearing screening and diagnostic devices, thereby positively accelerating the market for hearing screening and diagnostic devices during the forecast period.

However, drawbacks/limitations of hearing screening and diagnostic devices and limited access to hearing loss services, particularly in low-income countries may restrict the growth of the overall hearing screening and diagnostic devices market.

Hearing Screening And Diagnostic Devices Market Segment Analysis:

Hearing Screening and Diagnostic Devices Market by Product (OAE/ABR Testing Devices, Audiometers, Otoscopes, and Tympanometers), Indication Type (Conductive Hearing Loss, Sensorineural Hearing Loss, and Combination Hearing Loss), End-User (Hospitals & Clinics, and Diagnostic Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the hearing screening and diagnostic devices market, the audiometers category held the highest revenue share of 37.71% in the year 2022.

The presence of various types of audiometers in the market owing to their characteristics and advantages, and the latest product launches, among others, will propel the demand for audiometers in the hearing screening and diagnostic devices market in the upcoming years.

There are various types of audiometry such as pure-tone, speech, suprathreshold, self-recording, impedance, etc., each assessing the specific hearing potential of the patient.

For example, pure-tone audiometry is regarded as the gold standard for assessing auditory sensitivity. Pure-tone audiometry is used to detect the extent of hearing loss as well as its etiology. It assists in determining the hearing thresholds at various frequencies.

In the case of subjective audiometry, the subjects are asked to respond when they hear the presented sound. This audiometric test can present systematically varying acoustic stimuli to the subjects and record their responses.

In December 2023, MedRx helped hearing care practitioners by incorporating speech-in-noise Audible Contrast Threshold (ACT) testing into its audiometers. The corporation provided a new speech-in-noise equivalent test through ACT. The ACT measures the quality of hearing in noisy environments. The ACT is intended to be done in the booth, complementing existing workflows while providing additional information to the doctor.

In addition, in October 2023, Auditdata launched the new Measure audiometer and the fitting unit, with cutting-edge solutions to help hearing clinics provide the best care experiences for their patients.

Therefore, due to the interplay of all the above-mentioned factors along with the recent launch of audiometers, the market for hearing screening and diagnostic devices is expected to grow substantially during the given forecast period.

North America is expected to dominate the overall Hearing Screening And Diagnostic Devices Market:

Among all the regions, North America accounted for a market share of 40.12% in the global hearing screening and diagnostic devices market in 2023.

This can be ascribed to the high patient population base associated with hearing loss, the presence of key market players, and regulatory relaxations, among others in the region, driving the market growth during the forecast period.

As per data from the Centers for Disease Control and Prevention, hearing loss is the third most common chronic physical condition in the United States and is twice as prevalent as diabetes or cancer.

The Hearing Loss Association of America also stated that an estimated 48 million Americans experienced hearing loss to some degree.

About 15.5% of American adults 18 years and over, have trouble hearing according to the most recent data from the National Health Interview Survey (NHIS), a household survey administered by the CDC.

Recent data published by the National Council on Aging (2023) stated that the number of Americans with hearing loss is expected to increase by 30 million in the next four decades.

The rising prevalence of hearing loss highlighted in the statistics above thus indicates a huge need for hearing screening and diagnosis, thereby leading to more product demand in the hearing screening and diagnostic devices market in the United States.

The presence of key market players in the region such as Natus Medical Incorporated, Intelligent Hearing Systems, and Starkey Laboratories is another contributing factor responsible for the growth of the hearing screening and diagnostic devices market in North America.

Further, exemption from some regulatory steps during the process of product approvals from regulatory authorities is also aiding the positive growth in the hearing screening and diagnostic devices market in the region. For Instance, in January 2020, the US FDA exempted several hearing test devices from 510(k) premarket notification.

Thus, the interplay of all the above-mentioned factors will lead to an increase in the United States hearing screening and diagnostic devices market growth during the forecast period from 2024-2030.

Hearing Screening And Diagnostic Devices Market Key Players:

Some of the key market players operating in the hearing screening and diagnostic devices market include Baxter, Demant A/S, Medtronic, Sync Vision, INVENTIS s.r.l., Otodynamics, American Diagnostic Corporation, Natus Medical Incorporated, Vivosonic, WiscMed, Path Medical GmbH, Firefly Global, Olympus Corporation, Orlvision GmbH, HEINE Optotechnik GmbH & Co.KG, and Others.

Recent Developmental Activities in the Hearing Screening And Diagnostic Devices Market:

• In October 2021, Natus Medical Incorporated entered into a strategic partnership with IAC Acoustics to further enhance the availability and quality of clinical audiology testing.
• In April 2021, Baxter (Hillrom) launched the new Welch Allyn® MacroView® Plus Otoscope to enhance caregivers' views and support in early diagnosis and treatment of diseases.

Key Takeaways from the Hearing Screening And Diagnostic Devices Market Report Study

• Market size analysis for current hearing screening and diagnostic devices market size (2023), and market forecast for 5 years (2024-2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global hearing screening and diagnostic devices market.
• Various opportunities available for the other competitors in the hearing screening and diagnostic devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current hearing screening and diagnostic devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for hearing screening and diagnostic devices market growth in the coming future?

Target Audience who can be benefited from this Hearing Screening And Diagnostic Devices Market Report Study

• Hearing Screening and Diagnostic Devices product providers
• Research organizations and consulting companies
• Hearing Screening and Diagnostic Devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in hearing screening and diagnostic devices
• Various End-users who want to know more about the hearing screening and diagnostic devices market and the latest developments in the hearing screening and diagnostic devices market.

Frequently Asked Questions for the Hearing Screening And Diagnostic Devices Market:

1. What are hearing screening and diagnostic devices?

Hearing Screening and Diagnostic Devices are used to assess the general hearing health of individuals. These provide a comprehensive assessment of an individual's hearing abilities and are employed to determine the type and the degree of hearing loss, as well as identify specific auditory disorders.

2. What is the market for global hearing screening and diagnostic devices?

The global hearing screening and diagnostic devices market was valued at USD 549.75 million in 2023 and is likely to register a CAGR of 3.96% during the forecast period from 2024 to 2030 to reach USD 692.37 million by 2030.

3. What are the drivers for the global hearing screening and diagnostic devices market?

The hearing screening and diagnostic devices market is observing a remarkable market growth owing to the increasing prevalence of hearing loss due to hearing disorders, hereditary disorders, and birth complications, rising geriatric population, surge in government and non-government programs for hearing loss, technological advancements in product development, among others during the forecast period.

4. Who are the key players operating in the global hearing screening and diagnostic devices market?

Some of the key market players operating in the hearing screening and diagnostic devices market are Baxter, Demant A/S, Medtronic, Sync Vision, INVENTIS s.r.l., Otodynamics, American Diagnostic Corporation, Natus Medical Incorporated, Vivosonic, WiscMed, Path Medical GmbH, Firefly Global, Olympus Corporation, Orlvision GmbH, HEINE Optotechnik GmbH & Co.KG, and Others.

5. Which region has the highest share in the hearing screening and diagnostic devices market?

North America is expected to dominate the overall hearing screening and diagnostic devices market during the forecast period from 2024-2030. Owing to factors such as the high patient population base associated with hearing loss, the presence of key market players, and regulatory relaxations, among others in the country, drive the market growth during the forecast period.


This product will be delivered within 3-5 business days.